Top Markets
Coin of the day
Frequency Therapeutics, Inc. Frequency Therapeutics, Inc.

Frequency Therapeutics, Inc.

FREQ
Rangering i aksjer #32265
Frequency Therapeutics, Inc. is a clinical-stage biotechnology company... Frequency Therapeutics, Inc. is a clinical-stage biotechnology company dedicated to developing treatments that unlock the body's inherent capacity for regeneration to restore impaired functions. Their "Progenitor Cell Activation" approach leverages small molecules to stimulate progenitor cells within the body, encouraging the formation of new, functional tissues. The company's flagship product candidate, FX-322, is currently in Phase IIa clinical trials, aiming to address the fundamental cause of sensorineural hearing loss. Beyond this, Frequency is also advancing therapies for various degenerative diseases, including multiple sclerosis, and ailments impacting muscles, the gastrointestinal system, skin, and bones. For the development and commercialization of FX-322, the company holds a license and collaboration agreement with Astellas Pharma Inc. Additionally, it maintains collaboration and licensing agreements with esteemed organizations such as Massachusetts Eye and Ear, the Massachusetts Institute of Technology, The Scripps Research Institute, and Cambridge Enterprises Limited. Founded in 2014, Frequency Therapeutics, Inc. is headquartered in Lexington, Massachusetts.
Aksjekurs
$0.2996
Sist synkronisert: 2023-11-03
Markedsverdi
$10.58M
Endring (1 dag)
5.94%
Endring (1 år)
0.00%
Land
US
Handel Frequency Therapeutics, Inc. (FREQ)

Kategori

Aksjeprishistorikk for Frequency Therapeutics, Inc. (FREQ)
Høyeste sluttskurs: $0.28 den 2023-11-01

Laveste sluttskurs: $13.59 den 2019-10-01
Aksjeprishistorikk for Frequency Therapeutics, Inc. fra 2019 til 2026
Årlig aksjeprisytelse
År Ytelse
2023 -87.96%
2022 -56.26%
2021 -84.19%
2020 93.19%
2019 0.00%
Aksjepris for lignende selskaper eller konkurrenter
Selskap Aksjepris Endring 1år% Land
$515.58 32.24%
US
$992.01 50.00%
NL
$111.17 -36.90%
AU
$736.64 6.99%
CH
$1.06K -6.61%
KR